University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacology and Experimental Therapeutics, Toledo, OH 43614, USA.
University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacology and Experimental Therapeutics, Toledo, OH 43614, USA; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Brain Res Bull. 2020 Dec;165:272-280. doi: 10.1016/j.brainresbull.2020.10.012. Epub 2020 Oct 16.
Chronic ethanol exposure induces impairments in CNS excitatory and inhibitory activity. These impairments are associated with glutamatergic dysfunction, including altered neuroplasticity. This study examined the effects of 6-week ethanol (15% and 30% v/v) consumption, by male alcohol-preferring P rats, on protein expression associated with neuroplasticity and glutamate transporter-1 (GLT-1) function. The latter regulates intra- and extra-synaptic glutamate levels. We focused on the shell and core subregions of the nucleus accumbens (Acb); i.e., shell (AcbSh) and core (AcbCo), for these measures. Chronic ethanol exposure increased the expression of BDNF, Arc and phosphorylated (p)-post-synaptic density protein-95 (p-PSD-95) in the AcbSh of P rats. Moreover, the ratio of phospho-neuronal nitric oxide synthase (p-nNOS) to total nNOS was also increased in the AcbSh. These changes in BDNF, Arc and p-nNOS/nNOS ratio were not observed in the AcbCo. Furthermore, chronic ethanol consumption reduced GLT-1 expression in the AcbSh. Alternatively, treatment with ceftriaxone (CEF), a known GLT-1 upregulator, abolished the effect of chronic ethanol consumption on BDNF expression in the AcbSh. Overall, the present findings confirm that chronic ethanol consumption modulates activity-associated synaptic proteins, including BDNF, Arc and nNOS in a subregion-specific (i.e., in the AcbSh but not AcbCo) manner. Thus, alterations in mesocorticolimbic glutamatergic homeostasis and neuroplasticity are possible functional targets for the treatment of alcohol use disorders.
慢性乙醇暴露会导致中枢神经系统兴奋和抑制活性受损。这些损伤与谷氨酸能功能障碍有关,包括神经可塑性改变。本研究通过雄性酒精偏好 P 大鼠,研究了 6 周乙醇(15%和 30% v/v)摄入对与神经可塑性和谷氨酸转运体-1(GLT-1)功能相关的蛋白质表达的影响。后者调节突触内和突触外谷氨酸水平。我们专注于伏隔核(Acb)的壳和核区;即壳(AcbSh)和核(AcbCo),用于这些测量。慢性乙醇暴露增加了 P 大鼠 AcbSh 中 BDNF、Arc 和磷酸化(p)-突触后密度蛋白-95(p-PSD-95)的表达。此外,AcbSh 中的磷酸化神经元型一氧化氮合酶(p-nNOS)与总 nNOS 的比值也增加。在 AcbCo 中未观察到 BDNF、Arc 和 p-nNOS/nNOS 比值的这些变化。此外,慢性乙醇消耗降低了 AcbSh 中的 GLT-1 表达。相反,用头孢曲松(CEF)治疗,一种已知的 GLT-1 上调剂,消除了慢性乙醇消耗对 AcbSh 中 BDNF 表达的影响。总的来说,本研究结果证实,慢性乙醇消耗以亚区特异性(即在 AcbSh 中,但不在 AcbCo 中)方式调节与活性相关的突触蛋白,包括 BDNF、Arc 和 nNOS。因此,中边缘皮质谷氨酸能稳态和神经可塑性的改变可能是治疗酒精使用障碍的功能靶点。